DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway

BACKGROUND: DNA methyltransferase 3A (DNMT3A) often mutate on arginine 882 (DNMT3A(R882)) in acute myeloid leukemia (AML). AML patients with DNMT3A R882 mutation are usually resistant to daunorubicin treatment; however, the associated mechanism is still unclear. Therefore, it is urgent to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Xuan, Zhong, Liang, Dan, Wenran, Wang, Xiao, Zhang, Zhonghui, Liu, Zhenyan, Lu, Yang, Shao, Xin, Zhou, Ziwei, Chen, Shuyu, Liu, Beizhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615155/
https://www.ncbi.nlm.nih.gov/pubmed/36303144
http://dx.doi.org/10.1186/s12964-022-00978-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615155/
https://www.ncbi.nlm.nih.gov/pubmed/36303144
http://dx.doi.org/10.1186/s12964-022-00978-1

Ejemplares similares